Dustin Haines
Gilead Sciences names its new health leader for Asia markets
Gilead Sciences names its new health leader for Asia markets
Dustin Haines has 20 years leadership in pharmaceuticals.
Most Read
1. Singapore’s AI tool analyses heart attack damage within one minute 2. How can Asia-Pacific prove medical research is worth the money? 3. China's healthcare sector set for global breakout 4. Obesity drains $45b annually from Australia’s economy 5. India’s medical devices sector set for decade of steady growthResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Demand was strong for AI-driven and digital healthcare solutions.
Commentary
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential